Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Kalbe Farma Tbk PT
SWB:LCLA
Kalbe Farma Tbk PT
SWB:LCLA
Price:
0.0295
EUR
-29.76%
Market Closed
Market Cap:
€1.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
K
|
Kalbe Farma Tbk PT
SWB:LCLA
|
ID |
|
Wendel SE
PAR:MF
|
FR |
Wall St Price Targets
LCLA Price Forecast
Based on 14 analysts
Based on 14 analysts
+61% Upside
from
€0.0295
today
Kalbe Farma Tbk PT (LCLA)’s 12-month stock price forecast through June 2027 has a consensus target of €0.0475, implying 61% upside. The forecast is based on price targets from 14 Wall Street analysts.
LCLA Analyst Rating
No ratings yet
No ratings yet
Kalbe Farma Tbk PT Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LCLA's stock price target?
Price Target
0.0475
EUR
0.0475
EUR
According to Wall Street analysts, the average 1-year price target for LCLA is 0.0475 EUR with a low forecast of 0.035 EUR and a high forecast of 0.0756 EUR.
What is the Revenue forecast for Kalbe Farma Tbk PT?
Projected CAGR
9%
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is 9%.
What is the Gross Profit forecast for Kalbe Farma Tbk PT?
Projected CAGR
8%
8%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 3 years is 8%.
What is the Operating Income forecast for Kalbe Farma Tbk PT?
Projected CAGR
7%
7%
Over the last 13 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 3 years is 7%.
What is the Pre-Tax Income forecast for Kalbe Farma Tbk PT?
Projected CAGR
6%
6%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 6%. The projected CAGR for the next 3 years is 6%.
What is the Net Income forecast for Kalbe Farma Tbk PT?
Projected CAGR
6%
6%
Over the last 13 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 3 years is 6%.